Palliative and End-of-life Care in Advanced Dementia: Evaluation of a Program of Organization of Care in Long-term Care

Dementia Clinical Trial

Official title:

Palliative and End-of-life Care in Advanced Dementia: Evaluation of a Program of Organization of Care in Long-term Care Settings

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01441726
• Other study ID #: MOP-114881
• Status: Completed
• Phase: N/A
• First received: September 7, 2011
• Last updated: March 30, 2015
• Start date: September 2012
• Est. completion date: October 2014

Study information

• Verified date: March 2015
• Source: Laval University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Canadian Institutes of Health Research
• Study type: Observational

Clinical Trial Summary

Rationale: In Canada, as in most industrialized countries, Alzheimer's disease and other related dementia are increasingly prevalent in older people. At an advanced stage, institutionalization in a long-term care (LTC) setting will be the fate of a majority of patients. A structured palliative care approach is increasingly used for cancer patients, but is still rarely accessible in LTC institutions for older people with advanced or terminal dementia. This approach should include a more systematic detection and treatment of pain and other physical and psychological symptoms during the last weeks of life, as well as better communications between patients, families and care staff, particularly relating to advanced care directives. Objectives: The general objective of this study is to implement and evaluate a multidisciplinary and multidimensional program of palliative and end-of-life care for older persons with terminal dementia in LTC facilities. Methodology: The intervention program will include five components:

1. daily involvement of a nurse from the regular staff in the LTC facility as a change agent;

2. awareness sessions with administrators and staff on the importance of high quality palliative care in dementia;

3. a training program for physicians and all the staff involved in direct care of patients;

4. systematic discussions with families and distribution to families of a document on different aspects of palliative care in dementia;

5. systematic clinical care by regular staff for the control of pain, respiratory symptoms and mouth care. The program will be implemented in two LTC settings (one in Quebec City and one in Sherbrooke, Quebec, Canada), and results will be compared with the LTC control settings where usual care will be applied without implementation of the program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 175
• Est. completion date: October 2014
• Est. primary completion date: October 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Residents with advanced dementia with a score of 7 on the Reisberg scale

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Dementia

Locations

Country	Name	City	State
Canada	Centre de santé et de services sociaux de la Vieille Capitale	Quebec City	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Laval University

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Family satisfaction with terminal care	Family Perception of Care Scale (FPCS): 25-item validated instrument including 4 components, yielding a score from 25 (negative perception) to 175 (highest positive perception of quality of palliative care)	1 year	No
Primary	Comfort scale in last two weeks of life	Comfort Assessment in Dying with Dementia (CAD-EOL): 14-item validated instrument including 4 sub-scales, yielding a score from 14 (low comfort level) to 42 (highest comfort level).	2 weeks	No